Skip to main content
Signal8

Vistagen Therapeutics, Inc. (VTGN)

VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical entity dedicated to advancing and commercializing innovative medications for anxiety, depression, and various other disorders impacting the central nervous system (CNS). A key component of its CNS pipeline is PH94B, a fast-acting neuroactive nasal spray currently in Phase III trials for the rapid treatment of anxiety in adults experiencing social anxiety disorder. PH94B also shows potential for addressing a broader spectrum of anxiety conditions, including adjustment disorder with anxiety, postpartum anxiety, post-traumatic stress disorder (PTSD), pre-procedural anxiety, and panic disorders. The company's CNS development initiatives further encompass PH10, another quick-acting neuroactive nasal spray, which is in preparation for Phase 2B clinical assessment as a standalone therapy for major depressive disorder (MDD). Additionally, VistaGen is developing AV-101, an oral N-methyl-D-aspartate receptor antagonist, which is being investigated in conjunction with oral probenecid for its potential application in treating levodopa-induced dyskinesia, MDD, neuropathic pain, and suicidal ideation. VistaGen has established various collaborations, including a contract research and development agreement with Cato Research Ltd., a licensing agreement with Pherin Pharmaceuticals, Inc., and a license and collaboration agreement with EverInsight Therapeutics Inc. Founded in 1998, VistaGen Therapeutics, Inc. is headquartered in South San Francisco, California.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

VistaGen Therapeutics, Inc. logo

VistaGen Therapeutics, Inc.

NASDAQ:VTGNHealthcare
-1.41%$0.1683
AH$0.1695+0.71%vs close
Mkt Cap$7.47M
Float44.21M
O/S44.38M
Vol
$ Vol
RVOL
Inst Own26.5%
SI5.6%
Earnings
Dilution
Financials Summary
Revenue$1.27M
Net Income-$69.69M
Total Assets$48.56M
Free Cash Flow-$66.44M
Debt & Equity
Debt 3%
Equity 97%
Total Debt$1.04M
Total Equity$35.52M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
  1. 1:30Reverse split
    Jun 7, 202330 shares → 1
Balance Sheet Details
Assets$48.56M
Liabilities$13.04M
Accounts Receivable$0
Accounts Payable$1.53M
Inventory$0
PP&E (Net)$1.23M
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2026-03-312025-03-312024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312010-12-312009-12-312008-12-312007-12-31
Revenue$1.27M$486K$1.06M-$227K$1.11M$1.09M$0$0$0$1.25M$0$0$0$200K$1.34M$0$0$0$0
YoY Growth161.1%-54.3%-568.7%-120.5%1.8%---------85.1%-----
Cost of Revenue$0$0$0$0$0$0$103K$91K$81K$0$54K$0$0$0$0$0$0$0$0
Gross Profit$1.27M$486K$1.06M-$227K$1.11M$1.09M-$103K$0$0$1.25M$0$0$0$200K$1.34M$0$0$0$0
Gross Margin100.0%100.0%100.0%100.0%100.0%100.0%---100.0%---100.0%100.0%----
Research and Development$54.97M$39.38M$20.02M$44.38M$35.41M$11.93M$13.33M$17.1M$7.76M$5.2M$3.93M$2.43M$2.48M$3.43M$5.39M$0$0$0$0
Selling, General, and Administrative$18.42M$17.08M$14.06M$14.66M$13.25M$7.1M$6.55M$7.43M$6.44M$5.87M$13.92M$4.25M$2.55M$3.56M$4.36M$9K$22K$16K$5K
Other$0$0$0$0$232K-$400$0-$49K$0$427K-$2K$0$0$0$641K$428$428$36$0
Total Operating Expenses$73.39M$56.46M$34.09M$59.04M$48.89M$19.02M$19.87M$24.53M$14.2M$11.5M$17.85M$6.68M$5.03M$6.99M$10.39M$9K$22K$16K$5K
Operating Income (EBIT)-$72.13M-$55.97M-$33.02M-$59.27M-$47.78M-$17.93M-$19.97M-$24.56M-$14.2M-$10.25M-$17.85M-$6.78M-$5.03M-$6.79M-$9.04M-$9K-$22K-$16K-$5K
Operating Margin-5683.7%-11517.1%-3103.5%26109.3%-4308.7%-1646.1%----819.9%----3389.8%-673.8%----
Interest Expense$0$0$0$23K$0$13K$15K$8K$9K$5K$777K$4.62M$1.56M$1M$1.89M$0$0$0$0
Interest Income$2.44M$4.56M$3.35M$49K$20K$15K$45K$0$0$0$0$5K$10K$30K$1K$0$0$0$0
Other Income (Expense)$2.45M$4.56M$3.66M$26K$20K$2K-$797K-$31K-$144K-$5K-$29.37M-$7.11M$2.06M-$6.09M-$3.16M-$9.47M$0$0$0
Income Before Tax (EBT)-$69.68M-$51.41M-$29.36M-$59.24M-$47.76M-$17.93M-$20.77M-$24.59M-$14.34M-$10.25M-$47.22M-$13.88M-$2.96M-$12.88M-$12.21M-$9K-$22K-$16K-$5K
Income Tax Expense$7K$7K$4K$6K$3K$3K$3K$3K$2K$2K$2K$2K$3K$4K$2K$30$30$30$30
Net Income-$69.69M-$51.42M-$29.36M-$59.25M-$47.76M-$17.93M-$20.77M-$24.59M-$14.35M-$10.26M-$47.22M-$13.89M-$2.97M-$12.89M-$12.21M-$9K-$22K-$16K-$5K
Net Income Margin-5491.3%-10579.8%-2759.6%26100.4%-4307.2%-1646.1%----820.4%----6430.5%-909.7%----
Supplementary Data
EPS-1.83-1.67-1.52-8.51-7.38-14.74-14.21-25.83-30.98-40.85-801.28-318.27-81.00-426.99-497.11-0.46-1.13-0.95-0.28
Diluted EPS-1.83-1.67-1.52-8.51-7.38-14.74-14.21-25.83-30.98-40.85-801.27-315.87-81.00-426.98-497.11-0.46-1.13-0.95-0.28
Weighted Average OS38.07M30.88M19.35M6.96M6.60M2.87M1.46M952,082463,001251,05458,93143,62936,64030,18024,56119,49519,49517,34016,999
EBITDA-$71.39M-$50.78M-$28.79M-$58.74M-$47.05M-$17.44M-$20.65M-$24.47M-$14.25M-$9.77M-$17.8M-$6.72M-$4.97M-$11.85M-$10.27M-$6.32M-$22K-$16K-$5K
EBITDA Margin-5625.9%-10447.7%-2705.8%25874.9%-4242.8%-1600.8%----781.3%----5910.8%-765.0%----
Balance Sheet
PeriodFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2026-03-312025-03-312024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312010-12-312009-12-312008-12-312007-12-31
Assets
Current Assets
Cash and Cash Equivalents$30.79M$67.13M$119.17M$16.64M$68.14M$103.11M$1.36M$13.1M$10.38M$2.92M$429K$70K-$6K$638K$81K$2K$556$22K$0
Short-Term Investments$14.61M$13.35M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Cash and Short-Term Investments$45.4M$80.48M$119.17M$16.64M$68.14M$103.11M$1.36M$13.1M$10.38M$2.92M$429K$70K-$6K$638K$81K$2K$556$22K$0
Accounts Receivable$0$0$0$803K$2.75M$41K$0$300K$0$0$0$0$3K$0$106K$0$0$0$0
Inventory$0$0$0$0$0$0$0$230K$0$0$0$0$31K$0$0$0$0$0$0
Other Current Assets$1.54M$1.59M$1.51M$66K-$2.22M$160K$118K$155K$557K$0$400K$0$13K$0$0$0$0$0$0
Total Current Assets$46.94M$82.08M$120.67M$17.51M$71M$104.12M$1.58M$13.65M$11.02M$3.38M$855K$106K$41K$672K$238K$2K$556$22K$0
Long-Term Assets
Property, Plant & Equipment Net$1.23M$1.81M$2.25M$2.77M$3.08M$3.59M$3.79M$313K$207K$287K$88K$117K$176K$181K$75K$392$820$1K$0
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$393K$454K$726K$815K$569K$577K$403K$48K$48K$48K$47K$47K$47K$29K$29K$0$0$0$0
Total Long-Term Assets$1.62M$2.27M$2.98M$3.58M$3.65M$4.16M$4.19M$361K$255K$334K$135K$164K$223K$210K$104K$392$820$1K$0
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$48.56M$84.34M$123.65M$21.09M$74.64M$108.28M$5.77M$14.01M$11.28M$3.71M$990K$270K$264K$882K$342K$2K$1K$23K$0
Liabilities
Current Liabilities
Accounts Payable$1.53M$653K$1.55M$2.47M$2.76M$838K$1.84M$1.05M$1.2M$867K$936K$2.25M$2.44M$1.35M$1.75M$3K$1K$2K$240
Short-Term Debt$96K$0$0$105K$0$0$57K$57K$54K$55K$44K$13.93M$2.13M$710K$751K$530$500$500$0
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$1.71M$2.59M$791K$714K$1.24M$1.42M$0$0$0$0$0$0$0$0$13K$0$0$0$0
Other Current Liabilities$323K$3.36M$1.62M$337K$66K$0$0$0$0$0$0$0$4K$219K$229K$0$0$0$0
Total Current Liabilities$12.79M$12.61M$5.12M$4.57M$5.77M$4.19M$2.77M$2.8M$1.46M$1.37M$1.79M$17.39M$5.21M$2.41M$3.18M$3K$2K$3K$240
Long-Term Liabilities
Long-Term Debt$0$0$0$0$0$0$0$0$0$0$27K$332K$4.79M$4.62M$2.75M$0$0$0$0
Long-Term Unearned Revenue$0$391K$0$2.31M$1.56M$2.49M$0$0$0$0$56K$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0-$56K$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$0$0$2.67M$0$0$6.27M$5.01M$4.13M$2.89M$1.72M$2.15M$3.09M$3.07M$6.39M$110K$0$0$0$0
Total Long-Term Liabilities$249K$1.34M$4.24M$4.43M$4.16M$12.11M$8.73M$4.14M$2.9M$1.73M$2.17M$3.42M$7.86M$11.02M$2.87M$3K$2K$3K$0
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0-$3K-$2K-$3K$0
Total Liabilities$13.04M$13.95M$9.37M$9.01M$9.93M$16.3M$11.5M$6.94M$4.36M$3.1M$3.97M$20.81M$13.06M$13.44M$6.05M$3K$2K$3K$240
Stockholders' Equity
Preferred Stock$0$0$0$0$0$4K$4K$4K$4K$4K$7K$500$500$500$400$0$49K$27K$0
Common Stock$40K$29K$27K$7K$7K$181K$49K$43K$23K$9K$3K$2K$26K$24K$19K$6K$6K$6K$0
Retained Earnings-$477.32M-$407.63M-$356.21M-$326.85M-$267.6M-$219.84M-$201.91M-$181.13M-$156.54M-$142M-$131.74M-$84.52M-$70.64B-$67.67T-$54.78M-$58K-$49K-$27K-$10K
Comprehensive Income & Other-$2K$5K$0$0$0$0$0-$4K-$4K-$4K-$7K-$500-$70.64M-$67.67M-$400$0-$49K-$27K$0
Other Stockholders' Equity$512.8M$477.99M$470.47M$338.93M$332.31M$311.64M$196.13M$188.17M$163.44M$142.61M$128.76M$63.98M$70.62B$67.67T$49.06M$51K$43K$41K-
Total Equity$35.52M$70.39M$114.29M$12.08M$64.72M$91.98M-$5.73M$7.08M$6.92M$616K-$2.98M-$20.54M-$12.8M-$12.56M-$5.71M-$1K-$124$20K$0
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$48.56M$84.34M$123.65M$21.09M$74.64M$108.28M$5.77M$14.01M$11.28M$3.71M$990K$270K$264K$882K$342K$2K$1K$23K$240
Supplementary Data
Total Debt$1.04M$1.51M$2.12M$2.71M$3.04M$3.72M$4.09M$67K$66K$69K$72K$14.26M$6.92M$5.35M$3.52M$530$500$500$0
Net Debt-$29.75M-$65.62M-$117.05M-$13.93M-$65.1M-$99.39M$2.74M-$13.03M-$10.31M-$2.85M-$357K$14.19M$6.93M$4.71M$3.44M-$1K$0-$21K$0
Cash Flow Statement
PeriodFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2026-03-312025-03-312024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312010-12-312009-12-312008-12-31
Operating Activities
Net Income-$69.69M-$51.42M-$29.36M-$59.25M-$47.76M-$17.93M-$20.77M-$24.59M-$14.35M-$10.26M-$47.22M-$13.89M-$2.97M-$12.89M-$12.21M-$9K-$22K-$16K
Depreciation & Amortization$733K$635K$568K$532K$711K$478K$103K$91K$81K$55K$54K$59K$55K$34K$46K$428$428$36
Deferred Income Tax$0$0$0$0$0$0$0$146K$439K$752K$36.06M$2.49M-$3.35M$5.71M$2.64M$0$0$0
Stock-Based Compensation$4M$4.32M$2.18M$3.34M$3.48M$2.31M$3.82M$3.44M$2.34M$851K$4.04M$2.46M$1.14M$1.24M$1.59M$0$0$0
Changes in Working Capital:
  Accounts Receivable$0$0$0$0$0-$41K$300K-$300K$0$0$0$0$0$106K$0$0$0$0
  Inventory$0$0$0$0$0$0$0-$20.77M$0$0$0$0$0$0$0$0$0$0
  Accounts Payable$828K$5.68M$522K$0$1.69B$0$0$22.7M$135M-$451.7M-$547.2M$2.02B$2.23B$0$2.84T$2K-$1K$2K
  Other Working Capital-$1.77M-$921K$271K$2.03M-$1.69B$3.12M-$140K$91K-$134.33M$451.02M$546.68M-$2.02B-$2.23B$1.47M-$2.84T$0$0$0
Total Working Capital Change-$938K$4.76M$793K$2.03M-$1.92M$3.08M$160K$1.72M$673K-$679K-$522K$2.13M$2.3M$1.47M$2.71M$2K-$1K$2K
Other Non-Cash Items-$543K-$389K$6K$3.64M$232K$0$933K$4.66M$1.75M$2.02M$2.78M$3.98M$700K$971K$1.65M$0$0$0
Net Cash from Operating-$66.44M-$42.1M-$25.81M-$49.72M-$45.26M-$12.07M-$15.76M-$14.53M-$9.06M-$7.26M-$4.81M-$2.77M-$2.13M-$3.46M-$3.57M-$7K-$23K-$14K
Investing Activities
Capital Expenditures-$151K-$191K-$61K-$212K-$200K-$275K$0-$174K-$2K-$239K-$26K$0-$10K-$135K-$32K$0$0-$1K
Acquisitions$0$0$0-$528K$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Purchases of Investments-$22.3M-$24.98M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Sales of Investments$21.57M$12.03M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Investing Activities$0$0$0$0$0$0$0-$174M-$1.6M-$239.1M$0$0-$9.6M$0-$32.4B$0$0$0
Net Cash from Investing-$877K-$13.15M-$61K-$740K-$200K-$275K$0-$174K-$2K-$239K-$26K$0-$10K-$135K-$32K$0$0-$1K
Financing Activities
Debt Repaid--$985K$1.03M$3K-$221K$3K$3K$2K$1K$113K$308K$156K-$2.71M$306K---
Common Stock Issuance$30.88M$3.01M$129.38M$167K$4.44M$109.47M$3.6M$17.04M$16.72M$9.9M$280K$3.15M$1.08M$1.19M$2.68M$0$0$37K
Common Stock Repurchases$0$0$0-$174K$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0-$945.1M$0$0-$1.14B-$1.03B-$1.26B$0$0$0$0$0$0$0$0
Other Financing Activities$0$201K$8K$0$951.15M$5.01M$710K$1.16B$1.05B$1.27B$5.31M$0$1.65M$262K$1.17M$8K$2K$0
Net Cash from Financing$30.97M$3.21M$128.4M-$1.04M$10.48M$114.1M$4.01M$17.42M$16.52M$9.99M$5.19M$2.84M$1.5M$4.16M$3.54M$8K$2K$37K
Forex Effect$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Net Change in Cash-$36.34M-$52.03M$102.53M-$51.5M-$34.97M$101.75M-$11.75M$2.72M$7.46M$2.49M$359K$70K-$638K$557K-$58K$1K-$21K$22K
Supplementary Data
Operating Cash Flow-$66.44M-$42.1M-$25.81M-$49.72M-$45.26M-$12.07M-$15.76M-$14.53M-$9.06M-$7.26M-$4.81M-$2.77M-$2.13M-$3.46M-$3.57M-$7K-$23K-$14K
Capital Expenditure-$151K-$191K-$61K-$212K-$200K-$275K$0-$174K-$2K-$239K-$26K$0-$10K-$135K-$32K$0$0-$1K
Free Cash Flow-$66.44M-$42.29M-$25.87M-$49.93M-$45.46M-$12.35M-$15.76M-$14.7M-$9.06M-$7.5M-$4.83M-$2.77M-$2.14M-$3.6M-$3.6M-$7K-$23K-$16K
Cash at Beginning$67.13M$119.17M$16.64M$68.14M$103.11M$1.36M$13.1M$10.38M$2.92M$429K$70K$0$638K$81K$139K$556$22K$95
Cash at End$30.79M$67.13M$119.17M$16.64M$68.14M$103.11M$1.36M$13.1M$10.38M$2.92M$429K$70K$0$638K$81K$2K$556$22K